PFM Health Sciences’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.2M Buy
+313,679
New +$9.9M 1.12% 32

Other funds holding GMAB

PFM Health Sciences's GMAB Position: Q3 2026 in Review

PFM Health Sciences opened a new position in Genmab (GMAB) in Q3 2026: 313,679 shares worth $11.2M. The stake represents 1.12% of the portfolio and ranks #32 among its holdings.

333 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

  • PFM Health Sciences held 313,679 shares of Genmab worth $11.2M as of Q3 2026.
  • Genmab was a new PFM Health Sciences position in Q3 2026.
  • Genmab made up 1.12% of PFM Health Sciences's portfolio in Q3 2026, its #32 holding.
  • 333 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.